[Left ventricular hypertrophy in hemodialysis patient: Prevalence, electrocardiographic, echocardiographic study and

Soumaya Chargui1, Emna Allouche2, Wiem Dkhil3

  • 1Service de médecine interne A, hôpital Charles Nicolle, Tunis, Tunisie; Laboratoire de recherche de pathologie rénale (LR00SP01), Tunis, Tunisie.

Nephrologie & Therapeutique
|January 26, 2022
PubMed

Insights

Left ventricular hypertrophy (LVH) is common in hemodialysis patients. Combining electrocardiographic criteria improves LVH diagnosis accuracy, as single criteria show low sensitivity.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Diagnostics

Background:

  • Left ventricular hypertrophy (LVH) is a frequent cardiac complication in patients undergoing hemodialysis.
  • Diagnosis of LVH can be achieved through electrocardiography (ECG) and echocardiography.
  • The study investigates LVH prevalence and ECG criterion accuracy in hemodialysis patients.

Purpose of the Study:

  • To determine the prevalence of left ventricular hypertrophy (LVH) in hemodialysis patients.
  • To evaluate the diagnostic accuracy of various electrocardiographic (ECG) criteria for identifying LVH.
  • To compare the effectiveness of individual ECG criteria versus combined criteria.

Main Methods:

  • A cross-sectional retrospective study involving 60 hemodialysis patients (2017-2018).
  • Echocardiography defined LVH using specific mass index thresholds for men and women.
  • Fourteen ECG criteria were assessed for sensitivity, specificity, and ROC curve analysis.

Main Results:

  • Echocardiography revealed a 65% prevalence of LVH.
  • ECG criteria showed varied prevalence (5%-32%) and low sensitivity (5%-41%) but high specificity (≥90% for most).
  • Combining five ECG criteria yielded 48% sensitivity and 90% specificity; hypertension and HD duration were associated with LVH.

Conclusions:

  • Echocardiography confirms a high prevalence of LVH in hemodialysis patients.
  • Individual ECG criteria exhibit low sensitivity but high specificity for diagnosing LVH.
  • Combining multiple ECG criteria is recommended to enhance diagnostic accuracy for LVH in this population.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
92
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
69
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
109
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
48